NeuroscienceFrontiers in NeurosciencePeer-reviewed
Type-2-diabetes alters CSF but not plasma metabolomic and AD risk profiles in vervet monkeys
Kylie Kavanagh, Stephen M. Day, Morgan C. Pait…·Shannon L. Macauley
This study shows that type 2 diabetes in vervet monkeys alters cerebrospinal fluid metabolites and amyloid levels, but not plasma metabolites or AD risk profiles.
31 citations